1. Home
  2. BN vs GSK Comparison

BN vs GSK Comparison

Compare BN & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BN
  • GSK
  • Stock Information
  • Founded
  • BN 1997
  • GSK 1715
  • Country
  • BN Canada
  • GSK United Kingdom
  • Employees
  • BN N/A
  • GSK 68629
  • Industry
  • BN Other Consumer Services
  • GSK Biotechnology: Pharmaceutical Preparations
  • Sector
  • BN Consumer Discretionary
  • GSK Health Care
  • Exchange
  • BN Nasdaq
  • GSK Nasdaq
  • Market Cap
  • BN 90.5B
  • GSK 77.4B
  • IPO Year
  • BN N/A
  • GSK N/A
  • Fundamental
  • Price
  • BN $63.08
  • GSK $38.43
  • Analyst Decision
  • BN Buy
  • GSK Hold
  • Analyst Count
  • BN 10
  • GSK 3
  • Target Price
  • BN $61.60
  • GSK N/A
  • AVG Volume (30 Days)
  • BN 1.8M
  • GSK 4.9M
  • Earning Date
  • BN 08-07-2025
  • GSK 07-30-2025
  • Dividend Yield
  • BN 0.54%
  • GSK 4.09%
  • EPS Growth
  • BN N/A
  • GSK N/A
  • EPS
  • BN 0.29
  • GSK 0.98
  • Revenue
  • BN $83,605,000,000.00
  • GSK $40,735,668,430.00
  • Revenue This Year
  • BN N/A
  • GSK $6.70
  • Revenue Next Year
  • BN $12.72
  • GSK $5.42
  • P/E Ratio
  • BN $218.53
  • GSK $19.06
  • Revenue Growth
  • BN N/A
  • GSK 2.57
  • 52 Week Low
  • BN $40.82
  • GSK $31.72
  • 52 Week High
  • BN $62.78
  • GSK $44.67
  • Technical
  • Relative Strength Index (RSI)
  • BN 68.39
  • GSK 44.88
  • Support Level
  • BN $59.84
  • GSK $38.22
  • Resistance Level
  • BN $62.27
  • GSK $39.40
  • Average True Range (ATR)
  • BN 1.22
  • GSK 0.67
  • MACD
  • BN 0.23
  • GSK -0.22
  • Stochastic Oscillator
  • BN 98.83
  • GSK 14.88

About BN Brookfield Corporation Limited Voting Shares

Brookfield Corp is an investment firm focused on building long-term wealth for institutions and individuals. It has seven operating segments: Asset Management, Wealth Solutions, Renewable Power and Transition, Infrastructure, Private Equity, Real Estate and Corporate Activities. It invests in real assets that form the backbone of the economy to deliver risk-adjusted returns to stakeholders. The company generates the majority of its revenue from Asset Management. It has a geographic presence in the UK, the United States, Australia, Canada, Brazil, India, Colombia, Germany, Other Europe, Other Asia, and other countries.

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Share on Social Networks: